Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 19, 2024
Performance Evaluation of a Novel Artificial Intelligence-Assisted Digital Microscopy System for the Routine Analysis of Bone Marrow AspiratesAdam Bagg, Philipp W Raess, Deborah Rund, et al.
Annals of Hematology|June 13, 2025
Efficacy and safety of Glofitamab in patients with R/R DLBCL in real life setting- a retrospective studyRonit Gurion, Dmitri Guz, Meirav Kedmi, et al.
Leukemia & Lymphoma|May 7, 2015
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center studyAnat Gafter-Gvili, Elena Ribakovsky, Nadav Mizrahi, et al.
Hematological Oncology|November 2, 2019
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational studyShai Shimony, Netanel Horowitz, Elena Ribakovsky, et al.
Annals of Hematology|April 21, 2020
Clinical characteristics and outcomes of oligosecretory and non-secretory multiple myelomaMagdalini Migkou, Irit Avivi, Maria Gavriatopoulou, et al.
Blood|April 16, 2021
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaYair Herishanu, Irit Avivi, Anat Aharon, et al.
Blood|October 5, 2006
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcomeEldad J Dann, Rachel Bar-Shalom, Ada Tamir, et al.
American Journal of Hematology|June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter studyChava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.
European Journal of Haematology|September 26, 2021
Characteristics and recognition of early infections in patients treated with commercial anti-CD19 CAR-T cellsOfrat Beyar-Katz, Nino Kikozashvili, Yael Bar On, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumabIrit Avivi, Suparno Chakrabarti, Donald W Milligan, et al.
Pageof 20